awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q58736062
Q58736062
Item
http://www.wikidata.org/entity/Q58736062
Q58736062
about
Q58736062
Item
http://www.wikidata.org/entity/Q58736062
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
type
Item
P1433
Q58736062-568F0702-AD21-4198-81A6-6419C2EDDF13
P2093
Q58736062-5A22CB8A-3BFA-4583-BD63-FE82820DBE85
Q58736062-6B14AB9B-42E4-4280-8494-9DA07FB26C6B
Q58736062-C876EA7E-3670-4878-8323-F438C0B894BC
P2860
Q58736062-0113A518-609A-46AB-8674-7161A855FFEC
Q58736062-02ED5DFC-C488-44F9-9B35-6DDDC160AE0E
Q58736062-0F536A10-4D51-4DD9-9841-ECC8833ECDAA
Q58736062-10EFDDBC-DAE1-4D03-A28E-26F6DDF90C4C
Q58736062-12823EE4-2B2D-4B58-A3CE-373A04628022
Q58736062-190C7CA7-C918-4223-AC8F-9F8330B5E6E4
Q58736062-1C867774-3A95-472C-92AB-04F833CF98D4
Q58736062-27E0B5BF-7F64-44FE-9FEF-F6EFE433C138
Q58736062-2B06ACBE-C100-4C85-AEC1-5747015A5EE1
Q58736062-2C0DD80E-B9B6-4909-B3CB-9BE6FCD02EA2
Show more
P304
Q58736062-C07AD712-8EF7-4EF2-B55C-1B9449FE888D
P31
Q58736062-C5F5C39C-EAA4-4FF8-8417-896072224577
P356
Q58736062-7FD0D0DB-7FC8-4C71-97EE-63814F48051E
P433
Q58736062-32BE19F6-C3B8-424F-A11F-FB7C839B0D89
P478
Q58736062-798EB0B7-2925-411D-BE4D-B8F43C3B9A52
P577
Q58736062-8310A5AE-B202-4301-AA5D-026CEC103361
P698
Q58736062-AE58930F-54D7-4D69-9FB2-9354BD59F8F5
P932
Q58736062-36201043-6042-4736-AF83-6E89026A2FBD
P356
J.ISSN.1009-3419.2018.08.11
P1433
Zhongguo fei ai za zhi
P2093
Jiuwei Cui
http://www.w3.org/2001/XMLSchema#string
Naifei Chen
http://www.w3.org/2001/XMLSchema#string
Rilan Bai
http://www.w3.org/2001/XMLSchema#string
P2860
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis.
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.
Interferons and their stimulated genes in the tumor microenvironment
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
Show more
P304
641-648
http://www.w3.org/2001/XMLSchema#string
P31
scholarly article
P356
10.3779/J.ISSN.1009-3419.2018.08.11
http://www.w3.org/2001/XMLSchema#string
P433
8
http://www.w3.org/2001/XMLSchema#string
P478
21
http://www.w3.org/2001/XMLSchema#string
P577
2018-08-20T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P698
30172273
http://www.w3.org/2001/XMLSchema#string
P932
6105349
http://www.w3.org/2001/XMLSchema#string